Bone is the most frequent site of metastasis in breast cancer. This causes destructive osteolytic lesions. To achieve metastasis to bone, breast cancer cells must proliferate in a new microenvironment, arrest on extracellular matrix and invade. Breast cancer cells progress in the invasive processes only if they destroy bone with the assistance of osteoclasts. In this work, we present data suggesting that MCF-7 cells, an estradiol receptor–positive cell line that exhibits modest invasive capacity, proliferate in the presence of soluble fac-tors secreted by the osteogenic cell line SaOS-2. The cells acquire a more aggressive phenotype when cultured on an extracellular matrix produced by the same osseous cell line. Acquisition of the invasive ...
Inhibition of platelet-derived growth factor receptor (PDGFR) signaling restricts the growth of huma...
The cellular mechanisms that account for the increase in osteoclast numbers and bone resorption in s...
Aim: Estrogen receptor α-positive (ER+) subtypes of breast cancer have the greatest predilection for...
Artículo de publicación ISIBone is the most frequent site of metastasis in breast cancer. This caus...
Artículo de publicación ISIBone is the most frequent site of metastasis in breast cancer. This caus...
Breast cancers commonly cause osteolytic metastases in bone, a process that is dependent upon osteoc...
Free to read The mechanisms leading to colonization of metastatic breast cancer cells (BCa) in the s...
Bone metastasis, the migration of cancers to the bone, occurs in 65-75% of patients with advanced br...
Bone metastasis, the migration of cancers to the bone, occurs in 65-75% of patients with advanced br...
The skeleton is a preferred site of metastasis in patients with disseminated breast cancer. We have ...
Breast cancers commonly cause osteolytic metastases in bone, a process that is dependent upon osteoc...
The cellular mechanisms that account for the increase in osteoclast numbers and bone resorption in s...
Breast cancers commonly cause osteolytic metastases in bone, a process that is dependent upon osteoc...
It is increasingly evident that the microenvironment of bone can influence the cancer phenotype in m...
It is increasingly evident that the microenvironment of bone can influence the cancer phenotype in m...
Inhibition of platelet-derived growth factor receptor (PDGFR) signaling restricts the growth of huma...
The cellular mechanisms that account for the increase in osteoclast numbers and bone resorption in s...
Aim: Estrogen receptor α-positive (ER+) subtypes of breast cancer have the greatest predilection for...
Artículo de publicación ISIBone is the most frequent site of metastasis in breast cancer. This caus...
Artículo de publicación ISIBone is the most frequent site of metastasis in breast cancer. This caus...
Breast cancers commonly cause osteolytic metastases in bone, a process that is dependent upon osteoc...
Free to read The mechanisms leading to colonization of metastatic breast cancer cells (BCa) in the s...
Bone metastasis, the migration of cancers to the bone, occurs in 65-75% of patients with advanced br...
Bone metastasis, the migration of cancers to the bone, occurs in 65-75% of patients with advanced br...
The skeleton is a preferred site of metastasis in patients with disseminated breast cancer. We have ...
Breast cancers commonly cause osteolytic metastases in bone, a process that is dependent upon osteoc...
The cellular mechanisms that account for the increase in osteoclast numbers and bone resorption in s...
Breast cancers commonly cause osteolytic metastases in bone, a process that is dependent upon osteoc...
It is increasingly evident that the microenvironment of bone can influence the cancer phenotype in m...
It is increasingly evident that the microenvironment of bone can influence the cancer phenotype in m...
Inhibition of platelet-derived growth factor receptor (PDGFR) signaling restricts the growth of huma...
The cellular mechanisms that account for the increase in osteoclast numbers and bone resorption in s...
Aim: Estrogen receptor α-positive (ER+) subtypes of breast cancer have the greatest predilection for...